Want to join the conversation?
$HCN affirmed its 2016 normalized funds from operations per share guidance of $4.50-4.60 and normalized funds available for distribution per share outlook of $3.95-4.05, both representing a 3-5% increase. $HCN lifted 2016 EPS guidance to $2.74-2.84 from prior forecast of $2.07-2.17.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.